Rare diseases
Investigational molecules
Locations
Back to Germany22 clinical trials in Offenburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A Study of Pembrolizumab and Radiotherapy for Patients with Early-Stage Favorable Classic Hodgkin Lymphoma
GermanyStudy of loncastuximab tesirine and epcoritamab combination treatment for patients with relapsed or refractory diffuse large B-cell lymphoma
GermanyComparison of niraparib alone versus niraparib with bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel
GermanyStudy on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients
GermanyStudy on Ponatinib and Imatinib for Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia
GermanyStudy on Aconite Pain Oil to Prevent and Reduce Symptoms of Chemotherapy-Induced Polyneuropathy in Cancer Patients
GermanyStudy on Elacestrant for Treating ER+/HER2- Breast Cancer in Patients with ctDNA Relapse
GermanyStudy on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2
GermanyStudy of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B
GermanyGermanyStudy Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation
GermanyStudy on Thoracic Radiotherapy and Durvalumab for Elderly or Frail Stage III Non-Small Cell Lung Cancer Patients Unable to Undergo Chemotherapy
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on lymphomas and leukemias, including investigations of novel combination therapies for various B-cell lymphomas and advanced treatment approaches for acute myeloid leukemia.
Research emphasizes personalized treatment strategies and targeted therapies for better patient outcomes.
Comprehensive studies examining treatments for various solid tumors, with particular emphasis on breast cancer and gastrointestinal malignancies.
Trials explore innovative combinations of immunotherapy and targeted treatments to improve survival rates.
Studies focusing on managing treatment-related complications and improving quality of life for cancer patients, including research on chemotherapy-induced neuropathy.
Investigations aim to reduce treatment side effects and enhance patient comfort during therapy.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
